000147273 001__ 147273
000147273 005__ 20240229123022.0
000147273 0247_ $$2doi$$a10.1080/01635581.2019.1672762
000147273 0247_ $$2pmid$$apmid:31617773
000147273 0247_ $$2ISSN$$a0163-5581
000147273 0247_ $$2ISSN$$a1532-7914
000147273 0247_ $$2altmetric$$aaltmetric:86303366
000147273 037__ $$aDKFZ-2019-02396
000147273 041__ $$aeng
000147273 082__ $$a610
000147273 1001_ $$0P:(DE-He78)e16e2a17f7dd2e7f7e917c0382f19b2d$$aJaskulski, Stefanie$$b0$$eFirst author$$udkfz
000147273 245__ $$aPrognostic associations of circulating phytoestrogens and biomarker changes in long-term survivors of postmenopausal breast cancer.
000147273 260__ $$aNew York, NY$$bRoutledge, Taylor & Francis Group$$c2020
000147273 3367_ $$2DRIVER$$aarticle
000147273 3367_ $$2DataCite$$aOutput Types/Journal article
000147273 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1601378510_28064
000147273 3367_ $$2BibTeX$$aARTICLE
000147273 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000147273 3367_ $$00$$2EndNote$$aJournal Article
000147273 500__ $$a2020;72(7):1155-1169#EA:C020#LA:C020#
000147273 520__ $$aLignans are associated with improved postmenopausal breast cancer (BC) survival, but whether these associations, particularly with enterolactone (major lignan metabolite), persist over time is unclear. Little is known about other phytoestrogens on prognosis in long-term survivors. The study examines associations of prognosis with 1) circulating postdiagnosis enterolactone, 2) eight circulating phytoestrogen metabolites, and 3) changes in enterolactone and genistein. In a German cohort of 2,105 postmenopausal BC patients with blood samples collected at recruitment 2002-2005 (baseline) and re-interview in 2009 (follow-up), delay-entry Cox proportional hazards regression was used. Landmark analysis showed that circulating enterolactone (log2) associations with 5-year survival changed over time, with strongest hazard ratios of 0.89 (95% CI, 0.80-0.99) at blood draw (BD) and 0.86 (0.77-0.97) at 2 years post-BD for BC mortality, and 0.87 (0.80-0.95) at BD and 0.84 (0.76-0.92) at 3 years post-BD for all-cause mortality, which attenuated thereafter. In long-term survivors, increasing concentrations of genistein (1.17, 1.01-1.36), resveratrol (1.19, 1.02-1.40), and luteolin (1.96, 1.07-3.58) measured in follow-up blood samples were associated with poorer subsequent prognosis. Neither enterolactone at follow-up nor changes in enterolactone/genistein were associated with prognosis. Large long-term longitudinal studies with multiple phytoestrogen measurements are required to understand long-term effects of phytoestrogens after BC.
000147273 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000147273 588__ $$aDataset connected to CrossRef, PubMed,
000147273 7001_ $$0P:(DE-He78)bce1fdec5ce564e2666156d96aeabec9$$aJung, Audrey Ying-Chee$$b1$$udkfz
000147273 7001_ $$00000-0002-9694-9231$$aHuebner, Marianne$$b2
000147273 7001_ $$aPoschet, Gernot$$b3
000147273 7001_ $$00000-0002-6238-4818$$aHell, Rüdiger$$b4
000147273 7001_ $$0P:(DE-He78)6519c85d61a3def7974665471b8a4f74$$aHüsing, Anika$$b5$$udkfz
000147273 7001_ $$0P:(DE-HGF)0$$aGonzalez-Maldonado, Sandra$$b6
000147273 7001_ $$0P:(DE-He78)6b04712f3afe72044d496a25505cb1ea$$aBehrens, Sabine$$b7$$udkfz
000147273 7001_ $$aObi, Nadia$$b8
000147273 7001_ $$00000-0002-8808-6667$$aBecher, Heiko$$b9
000147273 7001_ $$0P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253$$aChang-Claude, Jenny$$b10$$eLast author$$udkfz
000147273 773__ $$0PERI:(DE-600)2025822-7$$a10.1080/01635581.2019.1672762$$gp. 1 - 15$$n7$$p1155-1169$$tNutrition and cancer$$v72$$x1532-7914$$y2020
000147273 909CO $$ooai:inrepo02.dkfz.de:147273$$pVDB
000147273 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e16e2a17f7dd2e7f7e917c0382f19b2d$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000147273 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)bce1fdec5ce564e2666156d96aeabec9$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000147273 9101_ $$0I:(DE-HGF)0$$60000-0002-9694-9231$$aExternal Institute$$b2$$kExtern
000147273 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)6519c85d61a3def7974665471b8a4f74$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000147273 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000147273 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)6b04712f3afe72044d496a25505cb1ea$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000147273 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253$$aDeutsches Krebsforschungszentrum$$b10$$kDKFZ
000147273 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000147273 9141_ $$y2020
000147273 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000147273 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000147273 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000147273 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNUTR CANCER : 2017
000147273 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000147273 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000147273 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000147273 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000147273 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000147273 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000147273 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000147273 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000147273 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000147273 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000147273 9202_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000147273 9200_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000147273 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000147273 980__ $$ajournal
000147273 980__ $$aVDB
000147273 980__ $$aI:(DE-He78)C020-20160331
000147273 980__ $$aUNRESTRICTED